Cytochalasin B inhibits morphogenetic movement and muscle differentiation of activin-treated ectoderm in Xenopus

Keiko Tamai, Chika Yokota, Takashi Ariizumi, Makoto Asashima

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Xenopus ectodermal explants (animal caps) begin to elongate after treatment with the mesoderm inducing factor activin A. This phenomenon mimics the convergent extension of dorsal mesoderm during gastrulation. To analyze the relationship between elongation movement and muscle differentiation, animal caps were treated with colchicine, taxol, cytochalasin B and hydroxyurea (HUA)/aphidicolin following activin treatment. Cytochalasin B disrupted the organization of actin filaments and inhibited the elongation of the activin-treated explants. Muscle differentiation was also inhibited in these explants at the histologic and molecular levels. Colchicine and taxol, which are known to affect microtubule organization, had little effect on elongation of the activin-treated explants. Co-treatment with HUA and aphidicolin caused serious damage on the explants and they did not undergo elongation. These results suggest that actin filaments play an important role in the elongation movement that leads to muscle differentiation of activin- treated explants.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalDevelopment Growth and Differentiation
Volume41
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Keywords

  • Activin A
  • Cytochalasin B
  • Morphogenetic movement
  • Muscle differentiation
  • Xenopus

Fingerprint

Dive into the research topics of 'Cytochalasin B inhibits morphogenetic movement and muscle differentiation of activin-treated ectoderm in Xenopus'. Together they form a unique fingerprint.

Cite this